Skip to main content

Table 4 Patients with prescriptions exceeding the recommended daily dose at 6 months by intervention and control group

From: How to improve drug dosing for patients with renal impairment in primary care - a cluster-randomized controlled trial

Variable

Intervention group (N = 198)

Control group (N = 206)

Estimated model adjusted ICC

Adjusted OR (95% CI)

p-value

Patients with ≥1 prescription exceeding recommended maximum dose [N] (%)

38 (19.2)

71 (34.5)

0.001

0.46 (0.26;0.82)

0.008

Patients with ≥1 prescription exceeding recommended standard dose by >30% [N] (%)

94 (47.5)

121 (58.7)

0.039

0.66 (0.36;1.21)

0.180

  1. Adjusted for underlying diagnosis, age, gender, serum creatinine, N patients with ≥1 prescription exceeding recommended maximum or standard dose at baseline.